Summary
The product Testomed C 250, manufactured by Deus Medical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number BS52537 (Manufactured 10/2020), was submitted by the reseller DeusPower.Shop and analyzed by Janoshik Analytical. The analysis measured a concentration of 254.44 mg/ml, slightly exceeding the labeled claim of 250 mg/ml by 1.78%.
The testing process began on 5 November 2020, with the sample received the same day, and analysis completed on 6 November 2020. The results confirm accurate dosing but raise the need for caution, as reseller-submitted samples may represent selected high-quality batches rather than typical product consistency. Independent third-party testing remains vital for comprehensive validation. This report aims to support educational efforts and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Testomed C 250
- Active Ingredient: Testosterone Cypionate
- Batch Number: BS52537 (Manufactured 10/2020)
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #08839
- Testing Ordered: 5 November 2020
- Sample Received: 5 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DeusPower.Shop (Reseller)
- Analysis Paid For By: DeusPower.Shop
Testing Results
- Specification: 250 mg/ml (as stated on the label)
- Measured Concentration: 254.44 mg/ml
- Accuracy: 101.78% (1.78% above the label claim)
- Variance: 1.78%
Verification Details
- Verification URL: https://janoshik.com/tests/08839_DJ31ALMJRE4K
Evaluation of Reseller-Submitted Testing
This analysis demonstrates the accuracy of the tested product but warrants careful evaluation due to its submission and funding by the reseller DeusPower.Shop. Resellers often select optimal batches for testing, which may not represent the consistency of products available to consumers. Independent third-party testing across multiple batches remains essential for unbiased validation.
Conclusion
The analysis confirms that Testomed C 250 is slightly overdosed, with a measured concentration of 254.44 mg/ml. This finding reflects good quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report serves as an educational resource to support harm reduction and informed consumer decisions.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
